Oncocyte Transitions to Revenue Generation as Multiple Payers Begin DetermaRx™ Reimbursements
Oncocyte has received its first diagnostic revenues from commercial payersSubmission of Medicare claims has commenced following final reimbursement decisionTest volumes […]